|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Franco-Czech laboratory for clinical research on obesity, French Institute of Health and Medical Research, Prague, Czech Republic; Obesity Research Unit , Inserm UPS U586, Louis Bugnard Institute, Toulouse Hospital, Paul Sabatier University, Toulouse, France; Department of Medical and Clinical Pharmacology, Faculty of Medicine, Toulouse, France
2 Franco-Czech laboratory for clinical research on obesity, French Institute of Health and Medical Research, Prague, Czech Republic; Department of Sports Medicine and Obesity Unit, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic
3 Franco-Czech laboratory for clinical research on obesity, French Institute of Health and Medical Research, Prague, Czech Republic; Franco-Czech laboratory for clinical research on obesity, French Institute of Health and Medical Research, Prague, Czech Republic
4 Franco-Czech laboratory for clinical research on obesity, French Institute of Health and Medical Research, Prague, Czech Republic; Obesity Research Unit , Inserm UPS U586, Louis Bugnard Institute, Toulouse Hospital, Paul Sabatier University, Toulouse, France
* To whom correspondence should be addressed. E-mail: moro{at}cict.fr.
Atrial Natriuretic Peptide (ANP) controls lipolysis in human adipocytes. Lipid mobilization is increased during repeated bouts of exercise, but the underlying mechanisms involved in this process have not yet been delineated. The relative involvement of catecholamine- and ANP-dependent pathways in the control of lipid mobilization during repeated bouts of exercise was thus investigated in subcutaneous adipose tissue (SCAT) by microdialysis. The study was performed in healthy males. Subjects performed two 45-min exercise bouts (E1 and E2) at 50% of their maximal oxygen uptake separated by a 60-min rest period. Extracellular glycerol concentration (EGC), reflecting SCAT lipolysis, was measured in a control probe perfused with Ringer solution and in two other probes perfused with either Ringer plus phentolamine (
1/2-AR antagonist) or Ringer plus both phentolamine and propranolol (
-AR antagonist). Plasma epinephrine, plasma glycerol and extracellular glycerol concentrations (EGC) were 1.7-, 1.6- and 1.2-fold higher in E2 than in E1 respectively. Phentolamine potentiated exercise-induced EGC increase during E2 only. Propranolol reduced the lipolytic rate during both E1 and E2, when compared to the probe with phentolamine. Plasma ANP concentration increased more during E2 than E1, and was correlated with the increase in EGC in the probe containing phentolamine plus propranolol. The results suggest that ANP is involved in the control of lipolysis during exercise and that it contributes to stimulation of lipolysis during repeated bouts of exercise.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |